These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 8796997
21. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. Sato H, Seiki M. J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706 [Abstract] [Full Text] [Related]
22. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Gallegos NC, Smales C, Savage FJ, Hembry RM, Boulos PB. Surg Oncol; 1995 Feb; 4(2):111-9. PubMed ID: 7551259 [Abstract] [Full Text] [Related]
23. Purification, identification and characterisation of seprase from bovine serum. Collins PJ, McMahon G, O'Brien P, O'Connor B. Int J Biochem Cell Biol; 2004 Nov; 36(11):2320-33. PubMed ID: 15313476 [Abstract] [Full Text] [Related]
24. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Mori Y, Kono K, Matsumoto Y, Fujii H, Yamane T, Mitsumata M, Chen WT. Oncology; 2004 Nov; 67(5-6):411-9. PubMed ID: 15713998 [Abstract] [Full Text] [Related]
25. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. Young TN, Rodriguez GC, Rinehart AR, Bast RC, Pizzo SV, Stack MS. Gynecol Oncol; 1996 Jul; 62(1):89-99. PubMed ID: 8690299 [Abstract] [Full Text] [Related]
26. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Schwartz JD, Shamamian P, Monea S, Whiting D, Marcus SG, Galloway AC, Mignatti P. Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143 [Abstract] [Full Text] [Related]
27. MMP-2: expression, activation and inhibition. Corcoran ML, Hewitt RE, Kleiner DE, Stetler-Stevenson WG. Enzyme Protein; 1996 Aug; 49(1-3):7-19. PubMed ID: 8796994 [Abstract] [Full Text] [Related]
28. Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas. Kjellman M, Enberg U, Höög A, Larsson C, Holst M, Farnebo LO, Sato H, Bäckdahl M. World J Surg; 1999 Mar; 23(3):237-42. PubMed ID: 9933692 [Abstract] [Full Text] [Related]
29. Pathological roles of invadopodia in cancer invasion and metastasis. Yamaguchi H. Eur J Cell Biol; 2012 Mar; 91(11-12):902-7. PubMed ID: 22658792 [Abstract] [Full Text] [Related]
30. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Sato H, Okada Y, Seiki M. Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203 [Abstract] [Full Text] [Related]
31. Emerging roles for proteinases in cancer. Noël A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A, Foidart JM. Invasion Metastasis; 1997 Jul; 17(5):221-39. PubMed ID: 9876217 [Abstract] [Full Text] [Related]
32. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Di Nezza LA, Misajon A, Zhang J, Jobling T, Quinn MA, Ostör AG, Nie G, Lopata A, Salamonsen LA. Cancer; 2002 Mar 01; 94(5):1466-75. PubMed ID: 11920503 [Abstract] [Full Text] [Related]